Excited to lead the $150M Series E of Verana Health with Johnson & Johnson Innovation (JJDC).
It is a privilege to work alongside Sujay Jadhav, the Verana team, and our medical society partners to expand the breadth of real world data to therapeutic areas that can improve the lives of patients.
Along with a great syndicate: GV, Casdin Capital, LLC, Brook Byers, Merck Global Health Innovation Fund, THVC, and Breyer Capital
https://lnkd.in/gMpNn_aT
16 views
View on LinkedIn